In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Follow-up study of fatty liver disease identified through imaging In a previous study ... The sensitivity to the hormone glucagon will be studied by giving glucagon into a blood vein – this way we can ...

Annabel Samimy, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Altimmune (ALT).Stay Ahead of the Market:Discover ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

This discovery changed the once fatal diagnosis of type 1 diabetes to a manageable disease. The importance ... later this factor was identified as glucagon. Since these pivotal discoveries ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

Stifel analyst Annabel Samimy initiated coverage of Altimmune (ALT) with a Buy rating and $18 price target The company is developing ...